Role of liver biopsy in nonalcoholic fatty liver disease.
about
Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesHepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjectsIndications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisInterferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric SurgeryComparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease.Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children.Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver diseaseDiagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Influence of cirrhosis in cardiac surgery outcomes.Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury.Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.Pharmacotherapies for fatigue in chronic liver disease (CLD): a systematic review and meta-analysis (protocol).Insulin-Like Growth Factor (IGF) System in Liver Diseases.Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice.An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease
P2860
Q26828855-8E44154D-A35B-402B-8647-E44CF1501708Q28595534-E98F70D6-6303-4404-BB31-54897A8BEE28Q30368738-384FEACB-936B-4D6C-878B-1650A08D6BB0Q35591165-C1393CBA-0968-4B50-B2B4-4F31A8FB8C4CQ35841934-1DF0AC6E-297F-4472-B219-0F893444A52BQ36303106-73D91D7C-6BFD-4F8C-99B2-0C3D9DFE693DQ36799486-783E7850-88EA-4A6E-B16C-681F4234A54EQ36900196-92B001C2-C06F-4B0B-811A-38E56921EB1AQ37358301-79F78D82-C5F7-44FC-8287-86A701E177B2Q37657130-20F9EB2D-A673-4E42-A024-FEA8D3BC6142Q37689828-732592C7-5921-4A9F-B9AD-AE7B39E4A4E3Q38443646-CA4F3F96-0C83-408E-B7E5-D55678C7DB5BQ41690998-835129F4-BE03-4E54-8F20-4F9F29CBDF47Q42610151-383670A5-80D0-483D-98B5-3162206495D1Q42703463-3744C8A1-3AD8-48A2-AAA5-C79CA9BC678EQ47191893-75E125EB-113D-467A-B091-DC56A6A15E1EQ47564331-91DFE836-81EE-4DF1-B148-4783E765B10EQ49420720-9194881F-E598-4CAA-A9B3-8B577601B773Q52558393-62546C3B-2B52-4948-A2B7-B2BC9553F4C5Q55404905-63735A61-2517-4B70-B644-38C5760EC0BAQ58748144-C274FC69-8109-4920-BAFE-B418B6360A1D
P2860
Role of liver biopsy in nonalcoholic fatty liver disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Role of liver biopsy in nonalcoholic fatty liver disease.
@en
type
label
Role of liver biopsy in nonalcoholic fatty liver disease.
@en
prefLabel
Role of liver biopsy in nonalcoholic fatty liver disease.
@en
P2860
P356
P1476
Role of liver biopsy in nonalcoholic fatty liver disease.
@en
P2093
Elizabeth M Brunt
I L Ke Nalbantoglu
P2860
P304
P356
10.3748/WJG.V20.I27.9026
P407
P577
2014-07-01T00:00:00Z